Essential Oils & Plant Extracts for Livestock Market Size Worth $4.2billion by 2026: Acumen Research and Consulting
/
Date14 Feb 2019
Email Print Friendly Share LOS ANGELES, Feb. 14, 2019 (GLOBE NEWSWIRE) — The global essential oils & plant extracts for livestock market size is anticipated... Read More →
MYnd Analytics Provides Business Update
/
Date14 Feb 2019
Email Print Friendly Share MISSION VIEJO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) — MYnd Analytics, Inc. (NASDAQ: MYND), a predictive analytics company aimed at improving... Read More →
Navigators Announces First Quarter 2019 Dividend
/
Date14 Feb 2019
Email Print Friendly Share STAMFORD, Conn., Feb. 14, 2019 (GLOBE NEWSWIRE) — The Navigators Group, Inc. (NASDAQ:NAVG) announced today that its Board of Directors declared... Read More →
Mercer International Inc. Reports Record 2018 Fourth Quarter and Year End Results and Announces Quarterly Cash Dividend of $0.125
/
Date14 Feb 2019
Email Print Friendly Share Selected Highlights Strong fourth quarter net income of $45.0 million ($0.68 per diluted share) and record Operating EBITDA* of $118.1 million... Read More →
Bridgeline Digital Acquires Natural Language Site Search and Analytics Products
/
Date14 Feb 2019
Email Print Friendly Share BURLINGTON, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based Web Content Management, eCommerce... Read More →
SJI to Host Fiscal 2018 Year-End Earnings Conference Call
/
Date14 Feb 2019
Email Print Friendly Share Folsom, NJ, Feb. 14, 2019 (GLOBE NEWSWIRE) — Media Contact: Marissa Travaline (609) 561-9000 ext. 4227 [email protected] Investor... Read More →
Raute's Financial statements, Corporate governance statement, Non-financial information statement and Remuneration statement 2018 published
/
Date14 Feb 2019
Email Print Friendly Share RAUTE CORPORATION STOCK EXCHANGE RELEASE 14 FEBRUARY 2019 at 10:30 p.m. RAUTE’S FINANCIAL STATEMENTS, CORPORATE GOVERNANCE STATEMENT, NON-FINANCIAL INFORMATION STATEMENT AND REMUNERATION... Read More →
Lysogene and Sarepta Therapeutics Announce Dosing of the First Patient in AAVance, a Phase 2/3 Clinical Trial Investigating LYS-SAF302, a Gene Therapy for the Treatment of MPS IIIA (Sanfilippo Syndrome Type A)
/
Date14 Feb 2019
Email Print Friendly Share — Trial to assess efficacy on neurodevelopmental status of MPS IIIA patients — CAMBRIDGE, Mass. and PARIS, Feb. 14, 2019 (GLOBE... Read More →
Avedro Announces Pricing of Initial Public Offering
/
Date14 Feb 2019
Email Print Friendly Share WALTHAM, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) — Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused... Read More →